Sancho JM, Abrisqueta P, Kumar A, Cordoba R, et al. Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL?112). Leuk Lymphoma 2024 Apr 10:1-11. doi: 10.1080/10428194.2024.2331626.
PMID: 38598516